Charles Nemeroff, an Emory University psychiatrist whose work has been highly influential and who has been at the center of a conflict-of-interest scandal, is moving to the University of Miami as its new psychiatry chair. Nemeroff resigned from the chair's position at Emory in December, amid growing Congressional scrutiny of payments he received from GlaxoSmithKline and did not report -- in violation of university rules, which are designed to ensure that federally supported research is not tainted by unknown financial conflicts of interest by researchers. The Miami Herald quoted Pascal Goldschmidt, dean of the University of Miami medical school, as acknowledging the controversy, but also calling Nemeroff "an extraordinary psychiatrist and scientist."
- More Scrutiny on Conflicts of Interest
- Quick Takes: Emory Removes Psychiatry Chair, Green Education Goals, Warning on Variable Debt, SUNY Canton Goes 4 Days, Help for Students From South Carolina Sports
- Double Standard at Emory?
- WE LOVE OUR STIMULANTS IN THIS COUNTRY
- THIRD-WORLD CORRUPTION AS A BEHAVIORAL SCIENCE -- Part One
- Conflict With My Interests
- Quick Takes: Why Students Lean Left, Reforms Pledged of Rutgers Athletics, Shooting Death at Northeast Lakeview, NIH Oversight of Emory, Gay Rights Supporters Arrested at Palm Beach Atlantic, SUNY Students Want to Pay More, From Hopkins to Salk Institute
- Quick Takes: Professors Protest 'Islamophobia' in Campaign, Emory Grant Frozen, Scholars From Afghanistan Missing, Trying to 'De-Nerdify' MIT
Search for Jobs